Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 22:35:102377.
doi: 10.1016/j.pmedr.2023.102377. eCollection 2023 Oct.

Prevalence and correlates of COVID-19 vaccine hesitancy among Chinese myocardial infarction survivors: A cross-sectional study

Yun Lin  1 , Wei Bai  2 , Zhaohui Su  3 , Todd Jackson  4 , Yu-Tao Xiang  2
Affiliations

Prevalence and correlates of COVID-19 vaccine hesitancy among Chinese myocardial infarction survivors: A cross-sectional study

Yun Lin et al. Prev Med Rep. .

Abstract

Individuals with cardiovascular diseases (CVDs) are at increased risk for morbidity and mortality from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although vaccinations should be a priority for individuals with high-risk CVDs, some may be hesitant to pursue such interventions. This cross-sectional study was designed to document the prevalence and correlates of COVID-19 vaccine hesitancy among myocardial infarction (MI) patients in China. Participants diagnosed with MI were recruited from Beijing Anzhen Hospital between October 17, 2021 and May 17, 2022. The primary outcome was prevalence rate of COVID-19 vaccine hesitancy. Demographics and attitudes toward vaccination were also assessed as potential correlates of vaccine hesitancy. A total of 565 MI patients were consecutively included for analyses. The percentage of participants that reported vaccine hesitancy was 32.7% (95 %CI: 28.9-36.6%), while 67.3% (95 %CI: 63.4-71.1%) viewed COVID-19 vaccines as safe and without serious side effects. MI patients who were married (OR = 0.47, 95 %CI: 0.23-0.95) and those who thought vaccines were safe (OR = 0.44, 95 %CI: 0.28-0.68) were less likely to report vaccine hesitancy. Conversely, participants who were older (OR = 1.04, 95 %CI: 1.02-1.07) and those who worried about being infected with COVID-19 (OR = 2.03, 95 %CI: 1.35-3.03) were more likely to be vaccine hesitant. A relatively high rate of vaccine hesitancy was found in Chinese MI patients. Immunization remains the leading strategy for reducing the health burden of COVID-19 in vulnerable groups including MI patients. Improving awareness of benefits of COVID-19 vaccines and emphasizing their safety could alleviate potential concerns of vaccine-hesitant MI survivors.

Keywords: COVID-19; Correlates; Myocardial infarction; Prevalence; Vaccine hesitancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Bai W., Cai H., Jin Y.u., Zhang Q., Cheung T., Su Z., Tang Y.-L., Ng C.H., Xiang Y.-T. COVID-19 vaccine hesitancy in community-dwelling and hospitalized patients with severe mental illness. Psychological. 2023;53(9):4288–4290. - PMC - PubMed
    1. Driggin E., Maddox T.M., Ferdinand K.C., Kirkpatrick J.N., Ky B., Morris A.A., Mullen J.B., Parikh S.A., Philbin D.M., Vaduganathan M. ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization. J. Am. Coll. Cardiol. 2021;77(15):1938–1948. - PMC - PubMed
    1. Fazlollahi A., Zahmatyar M., Noori M., Nejadghaderi S.A., Sullman M.J.M., Shekarriz-Foumani R., Kolahi A.A., Singh K., Safiri S. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev. Med. Virol. 2022;32:e2318. - PubMed
    1. Freeman D., Loe B.S., Chadwick A., Vaccari C., Waite F., Rosebrock L., Jenner L., Petit A., Lewandowsky S., Vanderslott S., Innocenti S., Larkin M., Giubilini A., Yu L.-M., McShane H., Pollard A.J., Lambe S. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychological. 2022;52(14):3127–3141. - PMC - PubMed
    1. Lazarus J.V., Ratzan S.C., Palayew A., Gostin L.O., Larson H.J., Rabin K., Kimball S., El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2021;27(2):225–228. - PMC - PubMed

LinkOut - more resources